SymbolINMD
NameINMODE LTD.
SectorHEALTH CARE
RegionMiddle East
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
AddressTAVOR BUILDING, SHAAR YOKNEAM,P.O. BOX 533, YOKNEAM, 2069206, Israel
Telephone+972 49096313
Fax
Email
Websitehttps://www.inmodemd.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001742692
Description

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and womens health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its products platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, Evolve, Evoke, and Morpheus8. The majority of its revenue comes from the United States.

Additional info from NASDAQ:
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and womens health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its products platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, Evolve, Evoke, and Morpheus8. The majority of its revenue comes from the United States.

2026-08-05 11:00

InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025

Read more
2026-08-05 07:12

InMode (Nasdaq: INMD) Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025

Read more
2026-07-30 22:58

Director Kenneth Nadav 🟢 acquired 2.0K shares of InMode Ltd. (INMD) Transaction Date: Jul 30, 2026 | Filing ID: 003735

Read more
2026-07-30 22:57

Director Nass Shlomo 🟢 acquired 2.0K shares of InMode Ltd. (INMD) Transaction Date: Jul 30, 2026 | Filing ID: 003733

Read more
2026-07-30 22:55

Director Ron Hadar 🟢 acquired 2.0K shares of InMode Ltd. (INMD) Transaction Date: Jul 30, 2026 | Filing ID: 003731

Read more
2026-07-28 20:00

Steel Partners Urges InMode Shareholders to Vote AGAINST the Re-Election of Dr. Hadar Ron and AGAINST Extraordinary Special Committee Compensation at the July 30 Annual General Meeting

Read more
2026-07-16 20:10

Steel Partners Holdings L.P. Issues Letter to InMode Ltd. Board of Directors Regarding the Company’s Persistent and Egregious Governance Failures

Read more
2026-07-13 09:23

InMode to Report Second Quarter 2026 Financial Results on August 5, 2026, Expects Q2 Revenue Between $95.2M-$95.4M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M

Read more
2026-07-10 09:26

InMode (NASDAQ: INMD) Confirms Receipt of Unsolicited Proposal

Read more
2026-07-02 17:19

Securities Fraud Investigation Into InMode Ltd. (INMD) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Read more